Oligometastatic Disease: Changing the Long-Term Management of Metastatic Lung Cancer

Session Format

Pre-Recorded

Session Type

Plenary Presentation

Topic Area

Lung Cancer

Description

Oligometastatic non-small cell lung cancer (NSCLC) represents a distinct subset of NSCLC patients with limited metastases who are living long-term after definitive treatment to all sites of active disease. One of the current limitations of aggressive treatment of oligometastatic NSCLC is the inability to accurately identify these patients before therapy. Three separate lectures will review clinical criteria, local ablative therapies, and emerging systemic therapies in oligometastatic NSCLC. Cases will be used to highlight multidisciplinary approaches to the diagnosis and treatment of oligometastatic disease.

Learning Objective 1

Describe the various definitions centered on the concept of oligometastatic disease.

Learning Objective 2

Identify patients with oligometastatic disease who will benefit from more aggressive therapy.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1 CME Credit